| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.0029 | 1 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.0034 | 1 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |